On September 16, INNOSCIENCE rose 5.19% in regular trading, trading at 42.66 HKD/share, with turnover of approximately 73.88 million HKD, amid a broad rally across the semiconductor sector.

On the news front, Goldman Sachs recently maintained a \"Buy\" rating on INNOSCIENCE with a target price of 114 HKD, based on a discounted EV/EBITDA valuation through 2030, citing confidence in the company's comprehensive GaN product portfolio covering 15V to 1200V. CLSA set a target of 112 HKD with an \"Outperform\" rating, while CMBIS assigned a target of 74.2 HKD. Daiwa also initiated coverage with a \"Buy\" rating, projecting 800V DC architecture adoption in AI data centers to drive GaN demand of USD 540 million to USD 4.5 billion between 2027 and 2030.

Fundamentally, INNOSCIENCE reported H1 revenue of RMB 834 million, up 50.6% year-on-year, with gross profit surging 156.5% and operating net cash flow turning positive at RMB 169 million for the first time. Management disclosed plans to expand GaN capacity to 70,000 wafers per month, targeting automotive and data center demand.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)